about
Evidence-based guideline: assessment and management of psychiatric disorders in individuals with MS: report of the Guideline Development Subcommittee of the American Academy of NeurologyUse of health services in people with multiple sclerosis with and without depressive symptoms: a two-year prospective study.Smaller cornu ammonis 2-3/dentate gyrus volumes and elevated cortisol in multiple sclerosis patients with depressive symptoms.Prevalence of Depression and Anxiety among Patients with Multiple Sclerosis Attending the MS Clinic at Sheikh Khalifa Medical City, UAE: Cross-Sectional StudyThe Goldman Consensus statement on depression in multiple sclerosis.Variations in and predictors of the occurrence of depressive symptoms and mood symptoms in multiple sclerosis: a longitudinal two-year studyComplementary and alternative medicine and coping in neuroimmunological diseases.Psychiatric issues in multiple sclerosis.Suicidal ideation among outpatients at general neurology clinics: prospective study.Complementary and alternative medicine in multiple sclerosis.Depression as a predictor of occupational transition in a multiple sclerosis cohort.Multiple sclerosis and depression.Exercising away the blues: can it help multiple sclerosis-related depression?An excessive risk of suicide may no longer be a reality for multiple sclerosis patients.Treatment of depression in people who have multiple sclerosis.Cost-effectiveness of nurse-delivered cognitive behavioural therapy (CBT) compared to supportive listening (SL) for adjustment to multiple sclerosis.Biological outcome measurements for behavioral interventions in multiple sclerosis.Multiple sclerosis and alcohol: a study of problem drinking.Self-rating makes the difference: identifying palliative care needs of patients feeling severely affected by multiple sclerosis.Neuropsychiatric symptoms in patients with multiple sclerosis.Personality functioning in patients with a progressive course of multiple sclerosis.Assessing mood in patients with multiple sclerosis.Quality of life in multiple sclerosis: should clinicians trust proxy ratings?
P2860
Q24615757-DA4A54C9-38DE-45FA-8082-D75C371B7F9BQ35001445-5552F2D2-4713-4A38-A3E2-D96A40F59395Q35065539-3C50C485-4746-4E8D-AD3D-A0674184BC02Q35882486-51DFDC90-30D9-4FC6-ABE9-F658474B24DDQ36163778-B839958D-BCAB-43B9-919A-D10BF4CC5B3BQ36654417-92EFB59E-2BDC-4F5C-9D8C-6111EA95E18DQ36822055-2E490120-1219-4C5A-B0F4-138AE91BDB25Q36972200-A642A8BC-2D85-4050-B416-80E25662DCB8Q37332265-C9E2FC31-D635-4AB3-9110-0C055489EA3AQ37419067-9CF49922-814B-4B03-9319-9EDF0D4DA639Q37632898-9C6CA434-9D88-4079-81F1-7B4A74A43581Q37953332-DFE4A8F7-B896-40B8-A2FD-6AA28C02A99AQ38152567-16BF88BA-5905-4B5D-8148-B168835115ACQ38904055-7578DDEA-DB1E-4C06-AED3-C7473E17DD18Q40206600-F323DE03-2477-4BEB-9F7D-6852BF5DEA7CQ42706315-A0F450A3-DF45-4AA6-B34D-18C9A9A24687Q42789516-09CAFECC-5D54-4BAF-8AB2-D99D0225ED39Q44881831-BCDBAE72-1DD8-4691-9BE3-44B05E76E435Q48307481-9D9AE549-1E5C-4E66-BFBD-1DC424A1DFFFQ48525581-C59AFE46-9099-4C9B-B678-FC6D09E081E7Q48954533-325D7909-E5B3-44FB-BBD9-CB636D0D69F6Q51011915-7CAF59AA-1EFD-4D90-9F9C-1DCEE04EB295Q53184660-FE9D52AE-1375-4DCC-A6F1-FF724F7EE298
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Multiple sclerosis, depression, and suicide.
@en
Multiple sclerosis, depression, and suicide.
@nl
type
label
Multiple sclerosis, depression, and suicide.
@en
Multiple sclerosis, depression, and suicide.
@nl
prefLabel
Multiple sclerosis, depression, and suicide.
@en
Multiple sclerosis, depression, and suicide.
@nl
P921
P356
P1433
P1476
Multiple sclerosis, depression, and suicide.
@en
P2093
Feinstein A
P304
P356
10.1136/BMJ.315.7110.691
P407
P577
1997-09-01T00:00:00Z